Fedha

Hisa unazofuatilia
Mtazamo: Thamani itaongezeka kwa asilimia 74.1·Thamani itapungua kwa asilimia 0.0
Nenda kwenye kichupo cha uchanganuzi
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
US$ 753.12
-1.27%
(-9.69) Siku 1
US$ 753.12
0.00% (0.00)
Baada ya saa
Imefungwa: 13 Okt, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya REGN...
Fungua
US$ 762.48
Juu
US$ 765.60
Chini
US$ 743.57
Mtaji wa soko
77.54B
Wastani wa kiasi cha mauzo
elfu 714.98
Kiasi cha mauzo ya hisa
elfu 629.52
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
US$ 0.94
Tarehe ya kutojumuisha gawio
18 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.62
Juu kwa wiki 52
US$ 859.34
Chini kwa wiki 52
US$ 553.86
EPS
US$ 40.45
Beta
0.16
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Fungua
US$ 762.48
Juu
US$ 765.60
Chini
US$ 743.57
Mtaji wa soko
77.54B
Wastani wa kiasi cha mauzo
elfu 714.98
Kiasi cha mauzo ya hisa
elfu 629.52
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
US$ 0.94
Tarehe ya kutojumuisha gawio
18 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
18.62
Juu kwa wiki 52
US$ 859.34
Chini kwa wiki 52
US$ 553.86
EPS
US$ 40.45
Beta
0.16
Hisa za wawekezaji
101.14M
Idadi ya wafanyakazi
elfu 15
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Kuhusu Regeneron Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Leonard Schleifer
Wafanyakazielfu 15.3
Lilianzishwa1988
Makao makuuTarrytown, New York, Marekani
Sekta-
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 22 waliotoa ukadiriaji wa hisa kwa REGN katika miezi 3 iliyopita
Nunua
Nunua
14
Shikilia
8
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 22 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya REGN katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 753.12
US$ 1,030.00 (+36.76%)
Wastani
US$ 858.43 (+13.98%)
Chini kabisa
US$ 740.00 (-1.74%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Evan Seigerman
BMO Capital
Buy
Maintained
US$ 920.00
+22.2%
10/12/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
US$ 908.00
+20.6%
10/12/2026
Geoff Meacham
Citi
Hold
Maintained
US$ 740.00
-1.7%
10/12/2026
Brian Abrahams
RBC Capital
Hold
Maintained
US$ 810.00
+7.6%
10/08/2026
Gregory Renza
Truist Financial
Buy
Maintained
US$ 780.00
+3.6%
10/07/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
US$ 779.00
+3.4%
10/07/2026
Chris Schott
J.P. Morgan
Buy
Reiterated
US$ 950.00
+26.1%
10/06/2026
Brian Skorney
Robert W. Baird
Hold
Maintained
US$ 761.00
+1%
10/02/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
US$ 972.00
+29.1%
10/01/2026
David Risinger
Leerink Partners
Hold
Maintained
-
-
10/02/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ 854.00
+13.4%
10/02/2026
Louise Chen
Scotiabank
Hold
Maintained
US$ 770.00
+2.2%
10/02/2026
Eliana Merle
Barclays
Buy
Maintained
US$ 917.00
+21.8%
10/02/2026
Akash Tewari
Jefferies
Buy
Maintained
US$ 930.00
+23.5%
10/01/2026
Jasper Hellweg
Argus Research
Buy
Upgraded
US$ 850.00
+12.9%
09/30/2026
Mohit Bansal
Wells Fargo
Hold
Maintained
US$ 750.00
-0.4%
09/28/2026
Eve Burstein
Bernstein
Hold
Maintained
US$ 756.00
+0.4%
09/25/2026
Rajesh Kumar
HSBC
Buy
Maintained
US$ 920.00
+22.2%
09/10/2026
Yatin Suneja
Guggenheim
Buy
Maintained
US$ 1,030.00
+36.8%
08/03/2026
Carter Gould
Cantor Fitzgerald
Buy
Maintained
US$ 795.00
+5.6%
07/30/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
US$ 960.00
+27.5%
07/30/2026
John Newman
Canaccord Genuity
Buy
Maintained
US$ 875.00
+16.2%
07/22/2026
Alexandria Hammond
Wolfe Research
Buy
Reiterated
US$ 860.00
+14.2%
05/18/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$ 825.00
+9.5%
05/18/2026
Nicholas Lorusso
TD Cowen
Buy
Maintained
US$ 960.00
+27.5%
05/06/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$ 865.00
+14.9%
04/30/2026
William Pickering
Bernstein
Buy
Maintained
US$ 921.00
+22.3%
04/08/2026
Christopher Raymond
Raymond James
Buy
Maintained
US$ 870.00
+15.5%
01/30/2026
Ripoti ya mwisho
30 Jul 2026
Kipindi cha Kifedha
Robo2 2026
US$ 14.29 / US$ 10.21
+39.99%umepitiliza
Mapato dhidi ya makadirio (USD)
4.29B / 3.82B
+12.22%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
3.75B
3.88B
3.61B
4.29B
Gharama ya bidhaa zilizouzwa
2.00B
2.21B
2.21B
2.21B
Gharama ya mapato
2.00B
2.21B
2.21B
2.21B
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
657.80M
775.00M
647.70M
662.10M
Gharama ya uendeshaji
647.80M
775.00M
647.70M
662.10M
Jumla ya gharama za uendeshaji
2.64B
2.99B
2.86B
2.87B
Mapato ya uendeshaji
1.11B
898.60M
744.80M
1.42B
Mapato mengine yasiyo ya uendeshaji
3.00M
958.50M
-7.30M
elfu 100.00
EBT ikijumuisha vipengee visivyo vya kawaida
1.76B
1.04B
831.20M
1.53B
EBT bila kujumuisha vipengee visivyo vya kawaida
1.27B
2.04B
908.10M
1.59B
Gharama ya kodi ya mapato
303.30M
199.10M
104.00M
230.90M
Kiwango cha kodi kinachotumika
17.20%
19.08%
12.51%
15.11%
Gharama nyingine za uendeshaji
-10.00M
-
-
-
Mapato halisi
1.46B
844.60M
727.20M
1.30B
Kiwango cha faida halisi
38.89%
21.74%
20.17%
30.23%
Mapato kwa kila hisa
11.83
11.44
9.47
14.29
Mapato ya riba na uwekezaji
175.10M
193.30M
183.50M
183.30M
Gharama ya riba
-19.30M
-12.20M
-12.90M
-11.00M
Jumla ya gharama halisi za riba
155.80M
181.10M
170.60M
172.30M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
1.25B
1.04B
868.00M
1.54B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google